Pharmamarketeer
wet- en regelgeving

PolarityTE seeks US FDA nod for OsteoTE, a human cellular and tissue─based product derived from patient's own bone

2 januari 2019
Pharma Biz

PolarityTE, Inc, a commercial─stage biotechnology company, announced that it registered OsteoTE with the US Food and Drug Administration (FDA) pursuant to applicable regulations governing human cells, tissues and cellular and tissue─based products (HCT/Ps).

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)